Developing evidence-based public health messages about blunts for young adults

Active Grant Awarded Last action

Award ID
R01DA064634
Recipient
Awarding agency
Obligated
$736,732

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 6% complete
Place of performance
Roxbury, MA 02118, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse awarded Trustees of Boston University, doing business as Boston University Medical Campus, $736,732 on August 7, 2026, under Drug Use and Addiction Research Programs (CFDA 93.279) through grant R01DA064634. The award funds development of evidence-based public health messages that inform young adults aged 18-34 about blunt use harms and increase intentions to reduce blunt use. Blunts are cannabis wrapped in cigarillo wrappers made from tobacco leaf.

Three aims structure the work: develop messages about blunt use harms, test those messages among young adults, and determine their effectiveness on intentions to reduce blunt use. Methods include a longitudinal randomized controlled trial and adaptation of a theory-driven conceptual model, with a focus on disseminating messages to state health departments, regulators, and prevention providers.

The period of performance ends May 31, 2031, and the place of performance is Roxbury, MA 02118, USA. The federal program supports basic, clinical, translational, and implementation research in substance use.

Description

Abstract
In the US, 15.1% (or 11.3 million) of young adults (18-34 years old) CO-use both tobacco and cannabis (i.e., use both products in the past 30 days or at the same time). Blunts (cannabis wrapped in cigarillo wrappers that are made from tobacco leaf) are one of the most common methods of tobacco and cannabis CO-use. Compared to those who use only tobacco or only cannabis, CO-use increases exposure to biomarkers of smoke combustion and carbon monoxide, increases cotinine levels and depression, lowers intentions to quit either product, and decreases cessation attempts. Nicotine also reinforces and enhances the effects of cannabis and vice versa. However, many young adults underestimate or do not know about the harms associated with smoking blunts. Effective messaging is needed to inform consumers about blunt use harms. To date, there is no public health messaging to educate consumers about blunt use harms, despite researchers and the 2024 national academies of sciences, engineering, and medicine report on cannabis explicitly calling for cannabis and blunt-specific public health messaging. The primary goal of this study is to develop evidence-based public health messages that inform young adults ages 18-34 about blunt use harms and increase intentions to reduce blunt use. The specific aims are: aim 1: develop messages about blunt use harms for young adults; aim 2: test messages about blunt use harms among young adults; aim 3: determine the effectiveness of messages about blunt use harms on intentions to reduce blunt use among young adults. Included within these aims are rigorous and innovative methods, including a longitudinal randomized controlled trial, adaptation of a theory-driven conceptual model, and a focus on disseminating messages to state health departments, regulators, and prevention providers who often lack resources for communicating about cannabis use harms, particularly the harms associated with smoking blunts. Led by interdisciplinary experts with a history of collaboration, our project can help meet a critical need by providing a better understanding of blunt smoking perceptions and optimal messages to effectively communicate blunt use harms to young adults . Our study also directly addresses two priority areas in nida's strategic plan, including developing and testing novel strategies for preventing drug use and facilitating research translation through education and partnerships.

Transactions

Action Obligated Date
Amendment $0
Original award $736,732

Subawards

Subrecipient Amount Awarded
University Of North Carolina At Chapel Hill The University of North Carolina at Chapel Hill will submit an investigator-initiated research proposal for PA-25-305 (R01 Clinical Trial Required). We will… $287,616

Quick answers

Who received award R01DA064634?

R01DA064634 was awarded to Trustees Of Boston University by National Institute on Drug Abuse (National Institutes of Health) on August 7, 2026.

How much is award R01DA064634 worth?

$736,732 has been obligated on R01DA064634.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award